Skip to main content
. Author manuscript; available in PMC: 2017 Mar 5.
Published in final edited form as: Breast Cancer Res Treat. 2016 Mar 5;156(1):183–194. doi: 10.1007/s10549-016-3724-0

Table 3.

Age-adjusted hazard ratios (HRs) and 95 % confidence intervals (CIs) for the association between BMI and 15-year all-cause and breast cancer-specific mortality stratified by gene methylation status (methylated vs. unmethylated tumors) among 1308 women diagnosed with a first primary breast cancer, Long Island Breast Cancer Study Project

All-cause mortality
Breast cancer-specific mortality
Unmethylated Methylated Unmethylated Methylated
Gene promoter
    Body Mass Index (BMI) categories No. deaths/cases HR 95 % CI No. deaths/cases HR 95 % CI No. deaths/cases HR 95 % CI HR 95 % CI
APC
    BMI < 25 kg/m2 55/195 1.00 Reference 52/158 1.00 Reference 25/195 1.00 Reference 23/158 1.00 Reference
    BMI 25–29.9 kg/m2 49/119 1.26 (0.86, 1.87) 44/131 0.99 (0.66, 1.47) 17/119 1.28 (0.69, 2.40) 20/131 1.03 (0.57, 1.88)
    BMI ≥ 30 kg/m2 32/94 0.99 (0.64, 1.53) 51/96 1.97 (1.33, 2.09) 9/94 0.81 (0.38, 1.76) 29/96 2.47 (1.43, 4.27)
p interaction 0.001 0.003
BRCA1
    BMI < 25 kg/m2 45/153 1.00 Reference 71/221 1.00 Reference 18/153 1.00 Reference 33/221 1.00 Reference
    BMI 25–29.9 kg/m2 34/104 0.96 (0.61, 1.49) 63/163 1.11 (0.79, 1.57) 9/104 0.78 (0.35, 1.75) 29/163 1.24 (0.75, 2.05)
    BMI ≥ 30 kg/m2 33/88 1.20 (0.77, 1.88) 54/114 1.45 (1.02, 2.06) 10/88 1.09 (0.50, 2.39) 29/114 1.89 (1.14, 3.12)
p interaction 0.489 0.151
CDH1
    BMI < 25 kg/m2 98/319 1.00 Reference 7/19 1.00 Reference 44/319 1.00 Reference <5/19 Not estimateda
    BMI 25–29.9 kg/m2 78/218 1.03 (0.77, 1.39) 7/16 1.38 (0.47, 4.01) 26/218 0.92 (0.56, 1.49) <5/16 not estimated
    BMI > 30 kg/m2 76/177 1.34 (1.00, 1.81) 5/9 2.15 (0.67, 6.95) 36/177 1.64 (1.05, 2.56) <5/9 Not estimated
p interaction 0.400 -
CYCLIND2
    BMI < 25 kg/m2 83/276 1.00 Reference 22/62 1.00 Reference 40/276 1.00 Reference 6/62 1.00 Reference
    BMI 25–29.9 kg/m2 63/184 1.04 (0.75, 1.45) 22/50 1.07 (0.59, 1.94) 20/184 0.80 (0.47, 1.36) 9/50 2.01 (0.70, 5.72)
    BMI > 30 kg/m2 59/149 1.30 (0.93, 1.81) 22/37 1.64 (0.91, 2.96) 28/149 1.42 (0.87, 2.31) 10/37 3.41 (1.21, 9.59)
p interaction 0.480 0.084
DAPK
    BMI < 25 kg/m2 92/297 1.00 Reference 13/41 1.00 Reference 39/297 1.00 Reference 7/41 1.00 Reference
    BMI 25–29.9 kg/m2 70/198 0.99 (0.73, 1.35) 15/36 1.45 (0.69, 3.05) 22/198 0.88 (0.52, 1.48) 7/36 1.35 (0.47, 3.86)
    BMI ≥ 30 kg/m2 67/156 1.33 (0.97, 1.82) 14/30 1.63 (0.77, 3.47) 32/156 1.69 (1.05, 2.70) 6/30 1.50 (0.50, 4.50)
p interaction 0.353 0.347
ESR1
    BMI < 25 kg/m2 57/195 1.00 Reference 58/175 1.00 Reference 30/195 1.00 Reference 21/175 1.00 Reference
    BMI 25–29.9 kg/m2 55/153 1.04 (0.72, 1.51) 42/110 1.13 (0.76, 1.69) 17/153 0.78 (0.43, 1.43) 21/110 1.61 (0.88, 2.95)
    BMI ≥ 30 kg/m2 49/108 1.53 (1.04, 2.24) 38/94 1.15 (0.77, 1.74) 20/108 1.48 (0.84, 2.62) 19/94 1.67 (0.89, 3.12)
p interaction 0.202 0.082
GSTP1
    BMI < 25 kg/m2 65/247 1.00 Reference 40/91 1.00 Reference 25/247 1.00 Reference 21/91 1.00 Reference
    BMI 25–29.9 kg/m2 56/169 1.14 (0.80, 1.63) 29/65 0.89 (0.55, 1.44) 19/169 1.16 (0.64, 2.12) 20/65 0.70 (0.3, 1.48)
    BMI ≥ 30 kg/m2 54/130 1.54 (1.08, 2.21) 27/56 1.07 (0.65, 1.74) 26/130 2.12 (1.22, 3.68) 12/56 1.05 (0.52, 2.14)
p interaction 0.192 0.080
HIN1
    BMI < 25 kg/m2 47/140 1.00 Reference 58/198 1.00 Reference 17/140 1.00 Reference 29/198 1.00 Reference
    BMI 25–29.9 kg/m2 28/78 1.00 (0.63, 1.60) 57/156 1.10 (0.76, 1.59) 12/78 1.25 (0.59, 2.62) 17/156 0.82 (0.45, 1.49)
    BMI ≥ 30 kg/m2 21/63 0.95 (0.57, 1.59) 60/123 1.65 (1.15, 2.36) 9/63 1.12 (0.50, 2.53) 29/123 1.95 (1.16, 3.28)
p interaction 0.077 0.071
CDKN2A
    BMI < 25 kg/m2 102/334 1.00 Reference <5/8 Not estimated 45/334 1.00 Reference <5/8 Not estimated
    BMI 25–29.9 kg/m2 86/226 1.11 (0.83, 1.48) 6/16 Not estimated 31/226 1.09 (0.69, 1.73) 6/16 Not estimated
    BMI ≥ 30 kg/m2 76/180 1.37 (1.02, 1.84) <5/6 Not estimated 34/180 1.56 (1.00, 2.44) <5/6 nOt estimated
p interaction - -
PR
    BMI < 25 kg/m2 94/321 1.00 Reference 22/53 1.00 Reference 37/321 1.00 Reference 14/53 1.00 Reference
    BMI 25–29.9 kg/m2 85/238 1.07 (0.79, 1.43) 12/29 1.33 (0.65, 2.71) 31/238 1.23 (0.76, 2.00) 7/29 1.05 (0.42, 2.61)
    BMI ≥ 30 kg/m2 78/183 1.40 (1.04, 1.89) 9/19 1.15 (0.53, 2.50) 34/183 1.91 (1.19, 3.07) 5/19 1.09 (0.39, 3.05)
p interaction 0.400 0.286
RARB
    BMI < 25 kg/m2 75/242 1.00 Reference 30/96 1.00 Reference 30/242 1.00 Reference 16/96 1.00 Reference
    BMI 25–29.9 kg/m2 57/166 1.01 (0.72, 1.43) 28/68 1.18 (0.70, 1.97) 15/166 0.77 (0.41, 1.44) 14/68 1.35 (0.65, 2.79)
    BMI ≥ 30 kg/m2 58/139 1.28 (0.91, 1.81) 23/47 1.66 (0.96, 2.85) 27/139 1.64 (0.97, 2.77) 11/47 1.81 (0.84, 3.90)
p interaction 0.434 0.284
RASSF1A
    BMI < 25 kg/m2 18/51 1.00 Reference 87/287 1.00 Reference 6/51 1.00 Reference 40/287 1.00 Reference
    BMI 25–29.9 kg/m2 7/29 0.61 (0.25, 1.49) 78/205 1.15 (0.84, 1.55) 2/29 0.57 (0.11, 2.91) 27/205 1.02 (0.63, 1.67)
    BMI ≥ 30 kg/m2 9/32 0.76 (0.34, 1.70) 72/154 1.53 (1.12, 2.09) 5/32 1.28 (0.38, 4.36) 33/154 1.77 (1.12, 2.82)
p interaction 0.050 0.355
TWIST1
    BMI < 25 kg/m2 93/291 1.00 Reference 12/47 1.00 Reference 40/291 1.00 Reference 6/47 1.00 Reference
    BMI 25–29.9 kg/m2 63/191 0.91 (0.66, 1.25) 22/43 2.12 (1.04, 4.31) 19/191 0.70 (0.41, 1.22) 10/43 2.49 (0.90, 6.86)
    BMI ≥ 30 kg/m2 65/162 1.19 (0.87, 1.63) 16/24 3.21 (1.51, 6.83) 31/162 1.39 (0.87, 2.24) 7/24 4.25 (1.43, 12.70)
p interaction 0.010 0.015
a

Point estimate was not calculated because cell sizes less than five